In a significant push to address persistent demographic challenges, the Russian government has unveiled plans to expand access to in-vitro fertilisation by 15% in 2026, framing the move as part of a broader national project for 'healthy longevity'. Health Minister Mikhail Murashko announced the target, noting that approximately 600,000 Russians have been born via IVF since its introduction in 1986, and highlighting the parallel rollout of advanced preimplantation and prenatal testing programmes. Viewed from Washington, this aggressive expansion of state-supported fertility treatment is interpreted as a direct countermeasure to Russia’s ageing population and low birth rates, long-term vulnerabilities that policymakers are keen to mitigate.

The IVF drive is embedded within a wider, ambitious public health strategy aiming to radically alter citizen behaviour. Minister Murashko concurrently declared a goal to increase the proportion of Russians adhering to a 'healthy lifestyle' by 1.5 times by 2030, with a near-term target of 11.5% by 2026. This objective confronts deeply entrenched habits: official figures place per capita alcohol consumption at 8.06 litres of pure ethanol annually, while tobacco use persists among 17.73% of citizens aged 15 and over. The health ministry claims a more than halving of smoking rates since 2009, attributing this to what it describes as a 'consistent and harsh' policy restricting the physical and economic availability of alcohol and nicotine.

Analysts in London note that this two-pronged approach—promoting reproduction while attempting to curb lifestyle-related morbidity—reflects a pragmatic, if formidable, calculation. The state is investing in the front-end of the demographic pipeline through IVF while seeking to extend productive lifespans and reduce the burden of chronic disease. The ministerial rhetoric explicitly frames 'healthy longevity' as a profitable investment for both the individual and the state, emphasising cognitive health and social connectivity as pillars of active ageing.

Looking forward, the success of these initiatives hinges on sustained funding and effective implementation across Russia’s vast regions. The planned IVF surge will test the capacity of the healthcare system, while the lifestyle targets demand continued regulatory pressure and public compliance. From a global perspective, Russia’s demographic experiment will be closely watched by other nations grappling with similar trends, offering a case study in whether state-directed health and fertility policies can meaningfully alter a population’s trajectory in an era of demographic transition.